Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study
新辅助帕妥珠单抗联合曲妥珠单抗和化疗方案治疗中国HER2阳性早期乳腺癌患者的疗效和安全性:一项真实世界回顾性多中心队列研究
期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-6054
Zhou, Meirong; Wang, Shouman; Wan, Nengbin; Yuan, Songlin; Hu, Xiongqiang; Zhou, Wei; Qing, Bohua; Liu, Mingwen; Sun, Weihua; Fan, Peizhi; Wang, Jianguo; Cao, Hong; Xu, Haifan; Dai, Bin; Tang, Peizhi; Qian, Liyuan; Zhao, Xi; Xiao, Jun; Zhou, Huaiying; Hu, Jinhui; Ding, Li; Tripodi, Domenico; Zdenkowski, Nicholas; O'Keefe, Thomas J; Sanchez, Alejandro Martin; Chen, Li; Zhang, Ping; Xu, Feng